22 results
8-K
EX-99.2
NMTRQ
9 Meters Biopharma, Inc.
30 Jun 22
9 Meters Biopharma Announces Positive Preliminary Results from Phase 2 Study of Vurolenatide in Short Bowel Syndrome
7:06am
. et al. Mortality and Economics in Short Bowel Syndrome. Best Practices Rest Clin Gastro, 2003 Dec;17(6):931-42 3. Transparency Market Research. Short
8-K
EX-99.2
fs5ne8so
23 Mar 22
9 Meters Biopharma Provides Business Update and Reports Financial Results
7:05am
8-K
EX-99.2
o02yt
15 Nov 21
9 Meters Biopharma Provides Business Update and Reports Financial Results for the Third Quarter 2021
7:34am
8-K
EX-99.1
yad9h9l lmffd44j
26 Jul 21
Other Events
7:32am
424B5
ujcv8 ti3x9sc
18 Mar 19
Prospectus supplement for primary offering
9:08am
424B5
ghk7649i
26 Oct 18
Prospectus supplement for primary offering
9:22pm